as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹52.98
Change
+1.31 (2.54%)
Open
₹52.7
Prev. Close
₹51.67
Day High
₹53.9
Day Low
₹50.04
Volume Analysis
Traded
29,742
Delivered
29,119
Delivery %
97.91%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Low return on equity (1.01%)
- •Below-average fundamentals quality score (39/100)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹58.44 | ₹56.17 | ₹54.58 | ₹52.31 | ₹50.72 | ₹48.45 | ₹46.86 |
| Fibonacci | ₹56.17 | ₹54.7 | ₹53.78 | ₹52.31 | ₹50.84 | ₹49.92 | ₹48.45 |
| Camarilla | ₹54.04 | ₹53.69 | ₹53.33 | ₹52.31 | ₹52.63 | ₹52.27 | ₹51.92 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
+1.88%
1 Month
+1.32%
3 Months
+3.44%
6 Months
-5.46%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹20.04
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
1.01%
Net margin 0.79% × asset turnover 0.58x × equity multiplier 2.21x
Company Overview
Sector
Chemicals
Market Cap
₹122 Cr
P/E (TTM)
46.6
ROE
1.01%
Book Value
₹41.5
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
Vital Chemtech Limited scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 39/100. The strongest factor is Financial Strength (81/100), while Growth (6/100) is the weakest area to weigh before deciding. Notably: Low return on equity (1.01%); below-average fundamentals quality score (39/100). FII holding has been falling.
TopFund Score — Fundamentals Quality
39/100 — WeakData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company's working capital requirements have reduced from 57.8 days to 41.0 days
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has low interest coverage ratio.
- −Company has a low return on equity of 1.56% over last 3 years.
- −Company might be capitalizing the interest cost
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Vital Chemtech Limited has informed about Copy of Newspaper Publication
Vital Chemtech Limited has informed about Resignation of Director/KMP/SMP
Vital Chemtech Limited has informed about Resignation of Director/KMP/SMP
Board approved Q2 FY2026-27 results; appointed two independent directors and noted two resignations effective 3 Nov 2026.
On 2 Nov 2026, board approved Q2/H1 results, appointed two independents, and noted two resignations.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales + | 35 | 34 | 27 | 35 | 51 |
| Expenses + | 32 | 31 | 25 | 31 | 45 |
| Operating Profit | 3 | 3 | 1 | 4 | 6 |
| OPM % | 8.13% | 7.49% | 5.05% | 11.33% | 11.9% |
| Other Income + | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 2 | 1 | -1 | 1 | 3 |
| Tax % | 31.18% | 21.14% | 16.67% | 12.5% | 24.78% |
| Net Profit + | 1 | 1 | -1 | 1 | 3 |
| EPS in Rs | 0 | 0 | -1 | 0 | 1 |
| Raw PDF | — | — | — | — | — |
| YoY Sales growth | — | — | — | 0 | 51 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 58 | 117 | 98 | 134 | 126 |
| Expenses + | 46 | 102 | 98 | 123 | 116 |
| Operating Profit | 12 | 15 | 0 | 11 | 10 |
| OPM % | 20.0% | 13.0% | 0.2% | 8.0% | 8.0% |
| Other Income + | 0 | 0 | 3 | 3 | 1 |
| Interest | 0 | 1 | 1 | 2 | 3 |
| Depreciation | 1 | 2 | 3 | 5 | 6 |
| Profit before tax | 11 | 11 | 0 | 6 | 2 |
| Tax % | 26.0% | 30.0% | 269.0% | 34.0% | 51.0% |
| Net Profit + | 8 | 8 | -1 | 4 | 1 |
| EPS in Rs | 5 | 3 | -1 | 2 | 0 |
| Dividend Payout % | 0.0% | 15.0% | -92.0% | 0.0% | 0.0% |
| Sales growth | — | 103 | -16 | 36 | -6 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Reserves | 8 | 66 | 60 | 76 | 75 |
| Borrowings + | 36 | 29 | 26 | 66 | 62 |
| Other Liabilities + | 30 | 19 | 27 | 41 | 58 |
| Total Liabilities | 81 | 138 | 137 | 207 | 219 |
| Fixed Assets + | 17 | 25 | 43 | 68 | 58 |
| CWIP | 0 | 0 | 0 | 15 | 43 |
| Investments | 3 | 15 | 35 | 13 | 13 |
| Other Assets + | 61 | 98 | 60 | 111 | 105 |
| Total Assets | 81 | 138 | 137 | 207 | 219 |
| Equity Capital | 7 | 24 | 24 | 24 | 24 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -13 | -8 | 14 | 6 | 5 |
| Cash from Investing Activity + | 1 | -26 | -35 | -39 | -5 |
| Cash from Financing Activity + | 18 | 58 | -9 | 33 | 1 |
| Net Cash Flow | 6 | 24 | -30 | 0 | 0 |
| Free Cash Flow | -22 | -18 | -7 | -40 | -19 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -91 | -36 | 7,410 | 75 | 59 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Nov 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Public | 16.07% | 21.14% | 24.83% | 25.68% | 26.16% | 24.54% | 24.54% | 24.7% | 24.7% | 24.7% |
| Promoters | 73.28% | 73.43% | 73.43% | 73.43% | 73.43% | 73.43% | 73.43% | 73.43% | 73.43% | 73.43% |
| FII | 6.53% | 3.62% | 0.78% | 0.56% | 0.16% | 1.78% | 1.78% | 1.62% | 1.62% | 1.62% |
| DII | 4.12% | 1.81% | 0.96% | 0.33% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Vital Chemtech Limited (this stock) | 122 | 46.6 | 1.23 | 1.01% |
| Chemcrux Enterprises Ltd. | 120 | 26.7 | 1.56 | 3.01% |
| Hindprakash Industry Ltd | 126 | 81.8 | 2.51 | 3.32% |
| Hindcon Chemicals Limited | 133 | 26.7 | 2.17 | 5.54% |
| Kanchi Karpooram Ltd. | 148 | 22.1 | 0.67 | 2.43% |
| Deep Polymers Ltd. | 90 | 13.2 | 0.85 | 6.54% |
| Mysore Petro Chemicals L | 84 | 4.26 | 0.34 | 0.21% |
Which Mutual Funds Hold Vital Chemtech Limited?
Frequently Asked Questions about Vital Chemtech Limited
Vital Chemtech Limited (VITAL) closed at ₹52.98 on NSE on 19 November 2026, up 1.31 (2.54%) from the previous close.
Vital Chemtech Limited trades on the NSE (National Stock Exchange of India) under the symbol VITAL.
Vital Chemtech Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 46.6.
Vital Chemtech Limited has a dividend yield of 0.0%.
Vital Chemtech Limited's 52-week high is ₹69.4 and its 52-week low is ₹35.4.
Vital Chemtech Limited has a market capitalisation of ₹122 crore.
Vital Chemtech Limited has a TopFund Quality Score of 39/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Vital Chemtech Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.